Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judith Feinberg

Showing results (81-90 of 161) with videos related to

Pageof 17
Sort By:
AIDS Patient Care and Stds|March 31, 2011
Health needs of HIV-infected women in the United States: insights from the women living positive surveyKathleen E Squires, Sally L Hodder, Judith Feinberg, et al.
The International Journal on Drug Policy|January 25, 2021
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North CarolinaJon E Zibbell, Nicholas C Peiper, Sarah E Duhart Clarke, et al.
AIDS (London, England)|December 5, 2015
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virusMelanie Thompson, Michael Saag, Edwin DeJesus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2026
Put us in, Coach: the case for recognizing the ID/Addiction workforceL Madeline McCrary, Ellen F Eaton, Ayako Wendy Fujita, et al.
Journal of Clinical Medicine|August 12, 2022
Provider Perspectives on Sleep Apnea from Appalachia: A Mixed Methods StudyRobert Stansbury, Toni Rudisill, Rachel Salyer, et al.
Annals of Internal Medicine|September 22, 2010
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trialJudith Currier, Dawn Averitt Bridge, Debbie Hagins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2024
Vertical Transmission of Hepatitis C Virus Among Women With a History of Injection Opioid UseJohn M Cafardi, Hong T Lin, Lana Lange, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)Pablo Tebas, Jiameng Zhang, Kevin Yarasheski, et al.
BMC Health Services Research|May 30, 2021
Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency departmentCarmen N Burrell, Melinda J Sharon, Stephen Davis, et al.
Drug and Alcohol Dependence|October 17, 2025
Implementation opportunities for optimizing retention on buprenorphine treatment for people with opioid use disorder in West VirginiaRoman Ivasiy, Lynn M Madden, Judith Feinberg, et al.
Pageof 17

Showing results (81-90 of 161) with videos related to

Sort By:
Pageof 17
AIDS Patient Care and Stds|March 31, 2011
Health needs of HIV-infected women in the United States: insights from the women living positive surveyKathleen E Squires, Sally L Hodder, Judith Feinberg, et al.
The International Journal on Drug Policy|January 25, 2021
Consumer discernment of fentanyl in illicit opioids confirmed by fentanyl test strips: Lessons from a syringe services program in North CarolinaJon E Zibbell, Nicholas C Peiper, Sarah E Duhart Clarke, et al.
AIDS (London, England)|December 5, 2015
A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virusMelanie Thompson, Michael Saag, Edwin DeJesus, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2026
Put us in, Coach: the case for recognizing the ID/Addiction workforceL Madeline McCrary, Ellen F Eaton, Ayako Wendy Fujita, et al.
Journal of Clinical Medicine|August 12, 2022
Provider Perspectives on Sleep Apnea from Appalachia: A Mixed Methods StudyRobert Stansbury, Toni Rudisill, Rachel Salyer, et al.
Annals of Internal Medicine|September 22, 2010
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trialJudith Currier, Dawn Averitt Bridge, Debbie Hagins, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2024
Vertical Transmission of Hepatitis C Virus Among Women With a History of Injection Opioid UseJohn M Cafardi, Hong T Lin, Lana Lange, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 29, 2007
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)Pablo Tebas, Jiameng Zhang, Kevin Yarasheski, et al.
BMC Health Services Research|May 30, 2021
Using the electronic medical record to increase testing for HIV and hepatitis C virus in an Appalachian emergency departmentCarmen N Burrell, Melinda J Sharon, Stephen Davis, et al.
Drug and Alcohol Dependence|October 17, 2025
Implementation opportunities for optimizing retention on buprenorphine treatment for people with opioid use disorder in West VirginiaRoman Ivasiy, Lynn M Madden, Judith Feinberg, et al.
Pageof 17